Saadat’s story is an example of how proper care can help individuals live full lives with CHB. But for every success story ...
A group of independent U.S. vaccine experts said on Thursday it plans to review existing data on administering the hepatitis ...
Both tobevibart (a monoclonal antibody) and elebsiran (a small interfering RNA) target hepatitis B virus surface antigen (HBsAg). Their efficacy and safety in the treatment of chronic hepatitis D ...
WASHINGTON -- Assessing sustained virological response (SVR) to hepatitis C virus (HCV) therapy at 4 weeks after treatment ...
WASHINGTON -- An investigational dual therapy appeared to show antiviral activity in patients with chronic hepatitis D virus (HDV) infection, according to the phase II SOLSTICE trial.
The Florida Department of Health found that several patients of Lily J. Voepel caught the bloodborne infection while under ...
Expired defibrillator pads and inadequate handwashing facilities led to the suspension of the surgery registration license of ...
Get key Q3 2025 insights on Vir Biotechnology’s accelerated hepatitis delta trial milestones, strong financials, and upcoming data catalysts.
Six drugs were granted a “Commissioner’s National Priority Voucher” from the FDA, which guarantees speedier reviews of drug ...
Background Globally, an estimated 296 million individuals live with chronic hepatitis B virus (HBV) infection, carrying ...
A panel of vaccine advisers to the Centers for Disease Control and Prevention chosen by Health Secretary Robert F. Kennedy Jr ...
Doylestown-based Hepatitis B Foundation to recognize French researcher for pioneering work in the area of hepatitis B and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback